AU6586298A - Glucagon-like peptide-1 analogs - Google Patents

Glucagon-like peptide-1 analogs

Info

Publication number
AU6586298A
AU6586298A AU65862/98A AU6586298A AU6586298A AU 6586298 A AU6586298 A AU 6586298A AU 65862/98 A AU65862/98 A AU 65862/98A AU 6586298 A AU6586298 A AU 6586298A AU 6586298 A AU6586298 A AU 6586298A
Authority
AU
Australia
Prior art keywords
glucagon
analogs
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU65862/98A
Inventor
James A Hoffmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU6586298A publication Critical patent/AU6586298A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU65862/98A 1997-03-31 1998-03-25 Glucagon-like peptide-1 analogs Abandoned AU6586298A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4116797P 1997-03-31 1997-03-31
US60041167 1997-03-31
PCT/US1998/005945 WO1998043658A1 (en) 1997-03-31 1998-03-25 Glucagon-like peptide-1 analogs

Publications (1)

Publication Number Publication Date
AU6586298A true AU6586298A (en) 1998-10-22

Family

ID=21915105

Family Applications (1)

Application Number Title Priority Date Filing Date
AU65862/98A Abandoned AU6586298A (en) 1997-03-31 1998-03-25 Glucagon-like peptide-1 analogs

Country Status (2)

Country Link
AU (1) AU6586298A (en)
WO (1) WO1998043658A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2777283B1 (en) * 1998-04-10 2000-11-24 Adir NOVEL GLUCAGON-PEPTIDE- 1 (7-37) ANALOGUE PEPTIDE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
US7259136B2 (en) 1999-04-30 2007-08-21 Amylin Pharmaceuticals, Inc. Compositions and methods for treating peripheral vascular disease
US6429197B1 (en) * 1998-10-08 2002-08-06 Bionebraska, Inc. Metabolic intervention with GLP-1 or its biologically active analogues to improve the function of the ischemic and reperfused brain
US6284725B1 (en) 1998-10-08 2001-09-04 Bionebraska, Inc. Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused tissue
RU2208015C2 (en) * 1998-12-07 2003-07-10 Сосьете Де Консей Де Решерш Э Д'Аппликасьон Сьентифик Сас Glp-1 analogues
US6514500B1 (en) 1999-10-15 2003-02-04 Conjuchem, Inc. Long lasting synthetic glucagon like peptide {GLP-!}
PT1180121E (en) 1999-05-17 2004-03-31 Conjuchem Inc LONG-TERM INSULINOTROPIC PEPTIDES
EP1263458B1 (en) 2000-03-08 2005-11-16 Novo Nordisk A/S Lowering serum cholesterol
WO2001089554A2 (en) 2000-05-19 2001-11-29 Bionebraska, Inc. Treatment of acute coronary syndrome with glp-1
EP2062593A3 (en) 2000-12-01 2011-08-17 Takeda Pharmaceutical Company Limited Method for producing preparation containing bioactive peptide
CN104826116A (en) 2003-11-20 2015-08-12 诺沃挪第克公司 Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices
EP2298337B1 (en) 2003-12-09 2017-02-22 Novo Nordisk A/S Regulation of food preference using GLP-1 agonists
BRPI0506694A (en) 2004-01-08 2007-05-02 Theratechnologies Inc Long-acting glucagon-like peptide-1 analogs
WO2005120492A1 (en) 2004-06-11 2005-12-22 Novo Nordisk A/S Counteracting drug-induced obesity using glp-1 agonists
ES2541633T3 (en) 2005-01-14 2015-07-22 Wuxi Grandchamp Pharmaceutical Technology Co., Ltd. Modified exendins and uses thereof
UA90718C2 (en) 2005-05-10 2010-05-25 Лаборатуар Фурнье С.А. Novel use of liver x receptor agonists
CA2648936C (en) 2006-04-20 2013-07-09 Amgen Inc. Glp-1 compounds
EP2066337A2 (en) 2006-08-04 2009-06-10 Amylin Pharmaceuticals, Inc. Use of exendins, exendin agonists and glp-1 receptor agonists for altering the concentration of fibrinogen
EP2555791B1 (en) 2010-04-09 2017-11-01 Sinai Health System Methods for treating disorders of the gastrointestinal tract using a glp-1 agonist
WO2014010586A1 (en) 2012-07-10 2014-01-16 武田薬品工業株式会社 Pharmaceutical preparation for injection
SG11202000940XA (en) 2017-08-24 2020-02-27 Novo Nordisk As Glp-1 compositions and uses thereof
CA3165359A1 (en) 2020-02-18 2021-07-22 Dorthe Kot Engelund Glp-1 compositions and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5705483A (en) * 1993-12-09 1998-01-06 Eli Lilly And Company Glucagon-like insulinotropic peptides, compositions and methods
WO1997029180A1 (en) * 1996-02-06 1997-08-14 Eli Lilly And Company Diabetes therapy

Also Published As

Publication number Publication date
WO1998043658A1 (en) 1998-10-08

Similar Documents

Publication Publication Date Title
IL136377A0 (en) Glucagon-like peptide-1 crystals
AU6586298A (en) Glucagon-like peptide-1 analogs
AU1617399A (en) Glp-1 formulations
HUP9903714A3 (en) Glp-1 derivatives
AU2610599A (en) N-terminally truncated glp-1 derivatives
ZA981343B (en) Sulfonylurea-glitazone combinations for diabetes
AU2524995A (en) Neurokinine (tachykinine) antagonists
AU9501798A (en) Low work-function electrode
AU9036098A (en) Parallel mechanism
AU1274099A (en) Low work-function electrode
AU9552498A (en) Phthalocyanine analogs
AU5335798A (en) Stomatic composition
AU8747498A (en) Food-preservative composition
AU9066598A (en) Substituted 4-benzoyl-pyrazoles
AU8917398A (en) Torch
AU5203698A (en) Fluid-treatment assemblies
EP0903415A3 (en) Structure expansée
AU2394697A (en) Porcine retrovirus
AU8121998A (en) Composition
AU5953598A (en) Plaque-inhibiting composites
ZA984895B (en) Solvent replacement
AU8072498A (en) Heregulin-like factor
AU1098499A (en) Emulsifier-lipid composition
AU6090898A (en) Substituted 4-benzoyl-pyrazoles
ZA977791B (en) GLP-1 derivatives.